Blood is an opaque fluid with a viscosity greater than that of water
(mean relative viscosity 4.75 at 18 °C).
• It has a specific gravity of 1.06 at 15 °C.
• Blood is bright red when oxygenated (in systemic arteries)
and dark red to purple when deoxygenated (in systemic veins).
• Blood is a mixture:
• Of a clear liquid (plasma)
• And of cellular elements (red blood cells, white blood cells, platelets).
• The hydrodynamic flow of blood in vessels is complex
and cannot be entirely predicted by simple Newtonian equations.
Plasma
• Plasma is a clear, yellowish fluid.
• It contains many substances in solution or suspension.
• Low-molecular-weight solutes cause a freezing-point depression of about 0.54 °C.
• Plasma contains:
• High concentrations of sodium and chloride ions
• Potassium, calcium, magnesium, phosphate, bicarbonate
• Traces of many other ions
• Glucose, amino acids, vitamins
• It also includes high-molecular-weight plasma proteins, such as:
• Clotting factors (e.g., prothrombin)
• Immunoglobulins and complement proteins (for immune defense)
• Glycoproteins, lipoproteins
• Peptide and steroid hormones
• Globulins for transporting hormones and iron.
Clinical Importance
• Plasma is responsible for transporting most molecules released or secreted by cells
in response to pathological or physiological stimuli.
• Therefore, routine chemical analysis of plasma is of great diagnostic importance.
• There is a growing interest in metabolomics:
• High-throughput analysis of small molecules or metabolites in serum
• As a tool to aid diagnosis and the understanding of diseases
(reference: Psychogios et al., 2011).
Blood Coagulation
• Fibrin is a protein that precipitates from plasma to form a clot.
• Clot formation is triggered by the release of materials from damaged cells and platelets, in the presence of calcium ions.
• When blood or plasma samples are left standing, they separate into:
• Clot
• Serum (clear, yellowish fluid)
• Prevention of clotting:
• Removal of calcium by adding agents such as:
• Citrate
• Oxalate
• Organic chelators (EDTA, EGTA)
• Heparin: prevents fibrin clot formation by interfering with the process.
Hemopoiesis (Blood Cell Production)
• Takes place in the bone marrow after birth.
• Produces:
• Erythrocytes (red blood cells)
• Leukocytes (white blood cells):
• Granulocytes:
• Neutrophils
• Eosinophils
• Basophils
• B lymphocytes
• Monocytes
• Platelets: cellular fragments derived from megakaryocytes.
• T lymphocytes develop in the thymus from bone marrow progenitors.
Circulation and Cell Migration
• Erythrocytes and platelets remain within the vascular system.
• Leukocytes can leave blood vessels and migrate into tissues, especially during:
• Inflammation
• Local infections
• Tissue damage
Lymphoid Tissues
• Main tissues:
• Thymus
• Lymph nodes
• Spleen
• Lymphoid follicles associated with:
• Gastrointestinal tract
• Respiratory tract
• Function: immune defense (populated by lymphocytes).
• Other cells present:
• Supportive stromal cells (non-hemopoietic origin):
• Thymic epithelium
• Follicular dendritic cells in lymph nodes and spleen
• Dendritic cells and macrophages (hemopoietic origin):
• Act as antigen-presenting cells (APCs).
• Also found in many tissues and organs.
Erythrocytes (RBCs):
• Make up 99% of blood cells
• Normal values:
• Males: 4.1–6.0 × 10⁶/μL
• Females: 3.9–5.5 × 10⁶/μL
Disorders:
• Polycythaemia: Too many RBCs (e.g. at high altitude, arterial hypoxia)
• Anaemia: Too few RBCs; causes vary (rarely structural)
Structure:
• Shape: Biconcave disc
• Diameter: ~7.1 μm (dry), ~7.8 μm (fresh)
• No nucleus
• Color: Pale red with lighter center (due to shape)
• Rouleaux: Cells stick in stacks
• Osmotic effects:
• Hypertonic: Crenated (shrink)
• Hypotonic: Swell, burst (haemolysis)
Membrane:
• Made of: 60% lipids, 40% proteins
• Main protein: Haemoglobin (33% of cell content)
Membrane Proteins:
• Glycophorins A & B: Carry negative charge (via sialic acid)
• Band 3 protein: Ion exchange (bicarbonate ↔ chloride)
Cytoskeleton:
• Key protein: Spectrin
• Forms tetramers → hexagonal lattice
• Other proteins: Ankyrin, actin, tropomyosin, protein 4.1
• Function: Shape maintenance, flexibility
• Defects cause: Hemolytic anemia
Fetal RBCs:
• Larger, nucleated, contain fetal hemoglobin (HbF)
• Replaced by adult RBCs after 4th month gestation
Haemoglobin (Hb):
• Globular protein, 67 kDa
• Composed of:
• Globulin + Haem group (contains iron)
• Iron binds oxygen (Fe²⁺ state maintained by glutathione)
• Tetramer: 4 polypeptide chains, each holds 1 haem
• Mutations → Hemoglobinopathies (e.g. sickle cell)
Lifespan of Erythrocytes:
• Live 100–120 days
• Ageing changes:
• Fragility increases
• Decrease in negative membrane charge (loss of glycoproteins)
• Lipid content reduces
• Old RBCs removed by spleen & liver macrophages
• Degradation process:
• Haemoglobin → globulin + porphyrin
• Globulin → amino acids
• Iron → reused (bound to transferrin) or stored (ferritin/haemosiderin)
• Haem → bilirubin, excreted in bile
• Free Hb binds haptoglobin → taken up by CD163 receptors
• Recognition signals for macrophages:
• Exposure of inner membrane phospholipids (e.g. phosphatidylserine)
• Loss of sialic acid
• Binding of autoantibodies
• Destruction rate: ~5 × 10¹¹ RBCs/day (~6 million/second)
• Replaced at the same rate by bone marrow
Blood Groups:
• 300+ red cell antigens
• 19 major blood group systems (e.g. ABO, Rhesus, Kell, Duffy, Kidd, etc.)
• Important in transfusion compatibility
• ABO & Rhesus = clinically most important
• Unmatched transfusion → agglutination & lysis
Leukocytes (White Blood Cells):
• 5 types (based on size, nucleus shape, cytoplasmic granules)
• Divided into:
• Granulocytes: contain visible granules
• Agranulocytes: no visible granules
Granulocytes:
• Eosinophils: stain with acidic dye (eosin)
• Basophils: stain with basic dyes
• Neutrophils: stain weakly with both
• All have multilobed nuclei
• Originate from myeloid series.
Neutrophils (Polymorphonuclear Leukocytes / Polymorphs):
• Named for their irregularly shaped, multilobed nuclei
• Belong to granulocytes; part of myeloid lineage
Haemoglobin Chains and Types:
• Five types of polypeptide chains:
• α, β, γ, δ, ε (ε only in early fetal life)
• Each Hb molecule = 2 α-chains + 2 others → various combinations:
• HbA (adult): 2 α + 2 β (major form)
• HbA₂: 2 α + 2 δ (~2% of adult Hb)
• HbF (fetal): 2 α + 2 γ (<1% in adults)
Haemoglobinopathies:
• Thalassaemia:
• One chain type underproduced or absent
• β-thalassaemia: Excess α-chains (α₄)
• α-thalassaemia: Excess β-chains (β₄)
• Sickle-cell disease:
• HbS: β-chain mutation (valine replaces glutamic acid)
• HbS polymerizes in low O₂ → RBC deformity
ABO Blood Group System:
• Determined by two allelic genes:
• AA → group A, BB → B, OO → O
• AB → AB, AO → A, BO → B
• Antigens = membrane glycolipids
• AB: No anti-A or anti-B antibodies → universal recipients
• O: No A/B antigens → universal donors
• ABO antibodies = IgM (do not cross placenta)
Rhesus (Rh) System:
• Controlled by three gene pairs: Cc, Dd (clinically most important), Ee
• D antigen defines Rh status:
• Dd or DD → Rh-positive, dd → Rh-negative
• Maternal sensitization:
• Rh-negative mother + Rh-positive fetus → anti-D (IgG) antibodies
• IgG crosses placenta, especially at birth → may destroy fetal RBCs
• First pregnancy: little/no damage
• Subsequent pregnancies: haemolytic disease of the newborn
• Causes of sensitization:
• Birth, miscarriage, abortion, amniocentesis
• Treatment/Prevention:
• Anti-D (Rh-immune globulin) given after first Rh⁺ pregnancy
• Exchange transfusion for newborn if needed.
Leukocytes and Their Functions
Eosinophils
• Have bilobed nuclei.
• Cytoplasm contains pink granules rich in major basic protein (MBP) and eosinophilic cationic proteins.
• MBP is cytotoxic: kills parasites and is involved in allergic reactions.
• Increase in parasitosis and allergies.
• Capable of chemotaxis, diapedesis, and phagocytosis.
Basophils
• Least abundant leukocytes in the blood.
• Nucleus is irregular, often obscured by coarse blue granules.
• Contain heparin (anticoagulant), histamine (vasodilator), and other inflammatory mediators.
• Active in allergic reactions and hypersensitivity.
• Precursors of mast cells.
• Not very phagocytic.
Monocytes
• Large cells with kidney-shaped nucleus.
• Cytoplasm is abundant and gray-blue.
• In tissues, they differentiate into macrophages.
• Involved in phagocytosis, antigen presentation, and inflammation modulation.
• Secrete cytokines, attract and activate other immune cells.
• Examples of tissue macrophages:
• Kupffer cells (liver)
• Alveolar macrophages (lungs)
• Microglia (brain)
Lymphocytes
• B lymphocytes:
• Produce antibodies.
• Differentiate into plasma cells after antigen stimulation.
• T lymphocytes:
• Helper T cells (CD4+): activate B cells and other immune cells.
• Cytotoxic T cells (CD8+): destroy infected or tumor cells.
• Natural Killer (NK) cells: part of innate immunity, attack virus-infected or abnormal cells.
• Fundamental in adaptive immune response.
PLATELETS – Study Notes in English
1. General Overview
• Platelets (thrombocytes) are small, oval or irregular discs, measuring 2–4 μm in diameter.
• Present in large numbers in blood: 200,000–400,000/μl.
• In fresh blood samples, they readily adhere to each other and to surfaces, unless treated with citrate or other calcium-chelating agents.
• They are anucleate cell fragments, derived from megakaryocytes in the bone marrow.
2. Structure
• Surrounded by a plasma membrane with a thick glycoprotein coat, which gives them adhesive properties.
• Just beneath the membrane: a band of 10 microtubules, associated with actin filaments, myosin, and other contractile proteins.
• The cytoplasm contains:
• Mitochondria
• Glycogen
• Scant smooth endoplasmic reticulum
• Tubular invaginations of the plasma membrane
• Three main types of granules:
• Alpha (α) granules (up to 500 nm): contain PDGF (platelet-derived growth factor), fibrinogen, and other proteins.
• Delta (δ) granules (up to 300 nm): contain serotonin (5-HT) taken up from plasma.
• Lambda (λ) granules (up to 250 nm): contain lysosomal enzymes.
3. Function: Hemostasis (Stopping Bleeding)
Activation
• When a blood vessel is damaged:
• Platelets become activated
• Form lamellipodia and filopodia (membrane extensions)
• Aggregate at the injury site, forming a temporary plug
Adhesion & Aggregation
• Platelets adhere to each other (agglutination) and to surrounding tissues.
• Promoted by the release of ADP and calcium ions from the platelets.
• The glycoprotein coat aids in adhesion.
Coagulation
• Alpha granules release PDGF, fibrinogen, and other factors.
• Along with substances from damaged tissue, they trigger a cascade of chemical reactions → leads to formation of insoluble fibrin.
• Fibrin forms a 3D meshwork: the fibrin clot.
• More platelets bind to the clot, inserting filopodia into the fibrin network → strong attachment.
Clot Retraction
• Platelets contract via actin-myosin interactions, tightening the clot and pulling the vessel walls together to reduce blood loss.
Clot Resolution
• After vessel repair (aided by PDGF), the clot is dissolved.
• Done by plasmin, activated from plasminogen by plasma activators.
• Lysosomal enzymes from lambda granules may assist.
4. Lifespan
• Platelets circulate for about 10 days.
• Removed mainly by splenic macrophages
Lymphocytes and Lymphoid Organs
1. Location of Lymphocytes
• Lymphocytes are found in many parts of the body, especially in areas exposed to infection (e.g., oropharynx).
• They are concentrated in lymphoid organs, divided into:
• Primary lymphoid organs: where lymphocytes are generated (e.g., bone marrow, thymus).
• Secondary (or peripheral) lymphoid organs: where mature lymphocytes become activated and initiate the immune response.
2. Secondary Lymphoid Organs
• These are the meeting points for B cells, T cells, and antigen-presenting cells.
• Include:
• Lymph nodes
• Spleen
• Mucosa-associated lymphoid tissue (MALT) – e.g., tonsils, Peyer’s patches (in the small intestine), lymphoid nodules in the respiratory and urogenital tracts, and skin.
• Lymphocytes enter secondary lymphoid tissues from the bloodstream (via high endothelial venules – HEVs) and exit through the lymphatic system.
• Dendritic cells enter via lymphatic vessels, carrying antigens from peripheral infection sites.
• After activation, lymphocytes migrate to other body sites to fight the infection.
• In sites of chronic inflammation, organized lymphoid structures may form called tertiary lymphoid organs.
3. Lymph Nodes
• Encapsulated centers for antigen presentation and for lymphocyte activation and proliferation.
• Filter particles and microbes through the activity of phagocytic macrophages.
• A young adult has about 450 lymph nodes, including:
• 60–70 in the head and neck
• 100 in the thorax
• Up to 250 in the abdomen and pelvis
• Numerous in: neck, mediastinum, posterior abdominal wall, mesenteries, pelvis, axillary and inguinal regions.
Microstructure
• Oval or kidney-shaped (0.1–2.5 cm).
• Hilum: the site where blood vessels enter/exit and where the efferent lymphatic vessel exits.
• Capsule: receives multiple afferent lymphatic vessels.
• Internal structure includes:
• Subcapsular sinus
• Cortex (with primary lymphoid follicles)
• Paracortex
• Medulla (with medullary sinuses)
• Efferent lymphatic vessel
4. Lymphocyte Origin
• All lymphocytes derive from pluripotent hematopoietic stem cells in the bone marrow.
• B lymphocytes: develop entirely in the bone marrow and then migrate to peripheral tissues.
• T lymphocytes: precursors migrate from the bone marrow to the thymus, where they mature and undergo selection (only 1–3% survive).
• Mature T cells enter the bloodstream and travel to secondary lymphoid organs.
Lymphatic and Vascular Supply of Lymph Nodes
• Lymph circulation: Lymph enters through afferent lymphatic vessels → subcapsular sinus → cortical sinuses → medullary sinuses → exits via efferent lymphatic vessels at the hilum.
• Conduit system: Sponge-like collagen network with fibroblastic reticular cells transports antigens and signaling molecules (e.g. chemokines).
• Dendritic cells: Sample antigens from lymph within conduits and present them to lymphocytes.
Blood Supply
• Arteries and veins enter at the hilum and branch throughout the cortex and medulla.
• Postcapillary high endothelial venules (HEVs) in the paracortex are key sites for lymphocyte entry from blood.
• Vessels become denser during immune activation due to increased lymphocyte activity.
Cellular Zones of the Lymph Node
1. Cortex
• Contains lymphoid follicles (mostly B cells and follicular dendritic cells).
• Primary follicles: Small, resting B cells.
• Secondary follicles: Contain germinal centers with activated, proliferating B cells.
2. Germinal Centers
• Dark zone: Rapidly dividing B cells (centroblasts) undergo antibody hypermutation.
• Light zone: Selection of B cells with high-affinity antibodies (centrocytes), interaction with FDCs and T cells.
• Tingible body macrophages: Phagocytose dying B cells.
3. Mantle zone: Surrounds germinal center, mostly resting B cells and a few helper T cells.
4. Paracortex (deep cortex)
• Rich in T cells (CD4+ and CD8+).
• Contains interdigitating dendritic cells, including Langerhans cells.
• Expands during T-cell immune responses.
5. Medulla
• Contains medullary cords with fewer lymphocytes, more macrophages, plasma cells, and some granulocytes.
Mucosa-Associated Lymphoid Tissue (MALT)
• Found in mucosal surfaces: gastrointestinal, respiratory, reproductive, urinary tracts, and skin.
• Includes tonsils, Peyer’s patches, and many microscopic lymphoid nodules.
• Mainly B cells, T cells, dendritic cells, and macrophages.
• Functions similarly to lymph nodes: lymphocyte activation and antigen presentation.
• No afferent lymphatics; lymphocytes enter via HEVs and exit through efferent vessels.
• After activation, lymphocytes travel to other mucosal sites to provide immune defense.
• Main role of B cells in MALT: Produce IgA antibodies secreted into mucosal linings.
HAEMOPOIESIS
• Definition: The formation of blood cells, primarily occurring in the bone marrow after birth.
• If bone marrow production is insufficient, the spleen and liver may resume haemopoietic activity.
BONE MARROW
• Location: Found in marrow cavities of all bones and in large Haversian canals.
• Forms:
• Red marrow: Active haemopoiesis.
• Yellow marrow: Mainly fat; inactive, but can revert to red marrow if needed.
• In old age: cranial bone marrow may become gelatinous.
Yellow Marrow
• Made of connective tissue and blood vessels.
• Contains many adipocytes.
• Small number of red marrow cells remain and may be reactivated.
Red Marrow
• Present throughout fetal skeleton and in children.
• After ~5 years: red marrow is gradually replaced by yellow marrow in long bones.
• In adults (20–25 years): red marrow is found in vertebrae, sternum, ribs, pelvis, clavicles, scapulae, and proximal femur and humerus.
• Structure:
• Stroma: loose connective tissue supporting haemopoietic cells (cords/islands).
• Rich vascular supply, with large sinusoids draining into large veins.
• No lymphatic vessels.
• Marrow = vascular + extravascular compartments, enclosed by bone and separated by endosteal cells.
STROMA
• Composed of type III collagen (reticulin) fibers from reticular cells (fibroblast-like).
• When haemopoiesis stops, stromal cells fill with fat (→ yellow marrow).
• Functions:
• Support haemopoiesis.
• Contain macrophages that:
• Remove debris (e.g. erythroblast nuclei).
• Transfer iron to erythroblasts.
• Help regulate cell differentiation/maturation.
MARROW SINUSOIDS
• Lined by endothelial cells with tight junctions and thin cytoplasm.
• Basal lamina is discontinuous.
• Blood cells pass into circulation via transient fenestrae in endothelium.
HAEMOPOIETIC TISSUE
• Cords/islands contain clusters of blood cell precursors.
• Each cluster has a central macrophage:
• Transfers iron for hemoglobin.
• Helps regulate cell development.
CELL LINEAGES
Haemopoietic Stem Cells (HSCs)
• Very rare (~0.05%).
• Pluripotent and self-renewing.
• Can differentiate into all blood cell types.
• Identified by surface markers like CD34.
• Found near endosteum or sinusoidal endothelium (niches).
• Also present in peripheral blood after cytokine treatment.
Progenitor Cells
• Arise from HSCs.
• More lineage-specific (not self-renewing).
• Examples:
• CFU-GM → granulocytes + monocytes.
• CFU-E → erythrocytes.
• Mature in marrow before entering circulation (except monocytes, which mature in tissues).
• Full blood regeneration from a single HSC takes months.
Bone Marrow Transplantation
• Requires pluripotent stem cells to succeed.
• Only 5% of normal HSCs are needed to repopulate marrow.
• T lymphocyte recovery is slower due to thymic involution with age.
Mesenchymal Stem Cells
• Also found in marrow and circulation.
• Can differentiate into non-haemopoietic cells (e.g. bone, cartilage).
• Investigated for use in organ repair.
Haemopoietic Stem Cells
• Stem Cells in Adult Bone Marrow: Very small population (~0.05%); self-renewing and pluripotent — give rise to all blood cell types including lymphocytes.
• Identification: Not visible morphologically; detected by surface markers like CD34.
• Location: Found in specific niches near the endosteum or sinusoidal endothelium; microenvironment regulates self-renewal vs differentiation.
• Peripheral Blood Presence: Found in low concentrations, especially after cytokine treatment.
Progenitor Cells
• Lineage-Restricted: Arise from stem cells; called colony-forming units (CFU).
• CFU-GM → granulocytes & monocytes.
• CFU-E → erythrocytes.
• Maturation: Occurs in the marrow; some cells mature in blood (e.g., erythrocytes), others in tissues (e.g., monocytes → macrophages).
Timeframe and Therapy
• Development Time: Full blood cell set from one pluripotent cell takes months.
• Later progenitors: Faster maturation but not self-renewing → important in bone marrow transplants.
• Success of Transplant: Requires pluripotent stem cells (only ~5% needed).
• T-cell Recovery: Slower due to thymus involution with age.
Mesenchymal Stem Cells
• Also present in marrow; can become non-haemopoietic cells.
• Also found in the bloodstream; investigated for tissue repair applications.
Lymphocytes
• Arise from a lymphoid progenitor cell (separate from myeloid).
• First identifiable form: lymphoblast, then prolymphocyte.
• B Cells:
• Develop entirely in the bone marrow.
• Undergo gene rearrangement for a unique antigen receptor.
• ~25% complete development; autoreactive ones are eliminated.
• Leave marrow as naive B cells with IgM and IgD receptors.
• Class switching occurs in peripheral tissues post-activation.
• T Cells:
• Require thymus for development.
• Progenitors migrate to thymus during fetal/early life.
• Undergo gene rearrangement of TCR.
• Recognize peptides presented with MHC molecules:
• CD8 T cells: MHC I.
• CD4 T cells: MHC II.
• MHC restriction: T cells only recognize peptides with self-MHC.
• Selection in thymus:
• Positive (moderate affinity to self-MHC) in cortex by epithelial cells.
• Negative (eliminates self-reactive cells) by dendritic cells and epithelial cells.
• ~95% of T-cell progenitors undergo apoptosis.
• Mature naive T cells exit thymus and go to peripheral tissues.
Thymic Environment
• Crucial for T-cell development.
• Stromal cells (epithelial, dendritic, fibroblasts) express MHC and secrete cytokines, chemokines, neuropeptides, and thymic hormones (e.g., thymulin).
• Apoptotic cells are removed by macrophages.
Macrophages
• Function: Phagocytose (engulf and digest) microorganisms, apoptotic cells, and tissue debris.
• Immunologically Silent: Uptake of apoptotic cells does not trigger antigen presentation or immune activation.
• Locations and Roles:
• Lungs: Alveolar macrophages (dust/heart failure cells) patrol respiratory surfaces, remove inhaled particles.
• Connective tissues: Kill invaders, clean up damaged cells.
• Pleural & peritoneal cavities: Act as scavengers.
• Lymph nodes: Line sinuses, filter lymph.
• Spleen & liver: Destroy old RBCs, recycle hemoglobin (iron, amino acids).
• Phagocytosis Enhancement:
• Increased by opsonization (coating with antibodies or complement).
• Uses Fc and C3 receptors.
• Fuses phagosome with lysosomes (contains hydrolases, bactericidal systems).
• Activated by cytokines like IFN-γ.
• Cytotoxic Role: Can release enzymes onto cell surfaces if targets are too large (e.g., parasites).
Macrophage Secretions
• Cytokines: IL-1 (stimulates lymphocytes), TNF-α (kills tumor cells, causes cachexia).
• Enzymes and Factors: Plasminogen activator, complement factors, clotting factors, lysozyme.
• Pathology: Can damage healthy tissue in diseases like rheumatoid arthritis.
Dendritic Cells
• Two Main Types:
• Myeloid (Classical) DCs: Professional antigen-presenting cells (APCs), from myeloid lineage.
• Plasmacytoid DCs: Also from lymphoid/myeloid origin, role in innate immunity.
• Locations:
• Immature DCs found in:
• Epidermis (Langerhans cells)
• Oral mucosa
• Dermis & most tissues (interstitial DCs)
• Functions:
• Immature DCs: Capture antigens, respond to chemotactic signals (e.g., defensins).
• Pattern Recognition: TLRs detect PAMPs (e.g., LPS, bacterial DNA).
• DAMPs Recognition: Respond to ATP, HMGB1 from damaged cells.
• Migration: Upon activation, DCs move to lymph nodes via lymphatics.
• In lymphatics: Called veiled cells.
• In lymph nodes: Become interdigitating DCs.
• Main Role: Present processed antigen to naive T cells, initiating immune responses.
Langerhans Cells
• Type: Immature dendritic cells.
• Location: Epidermis (especially in the stratum spinosum).
• Morphology: Irregular nucleus, clear cytoplasm, and Birbeck granules (specialized vesicles).
• Function: Capture and process antigens via endocytosis; mature into antigen-presenting cells (APCs).
• Activation: Upregulate MHC I & II, co-stimulatory, and adhesion molecules.
• Migration: Travel to lymph nodes to activate T lymphocytes.
Interdigitating Dendritic Cells
• Origin: Mature from immature dendritic cells found in peripheral tissues and blood.
• Location: T-cell zones of secondary lymphoid tissues:
• Paracortex of lymph nodes
• Interfollicular areas of MALT
• Periarteriolar sheath in spleen
• Function: Present antigen via:
• MHC I to CD8+ T cells
• MHC II to CD4+ T cells
• T cell activation requires:
• Antigen-MHC complex recognition (via TCR)
• Co-stimulatory signals
• Cytokine signaling (influences Th1/Th2 differentiation)
Follicular Dendritic Cells (FDCs)
• Origin: Non-haematopoietic (likely stromal).
• Location: Follicles of secondary lymphoid tissues (e.g., tonsils).
• Do not: Migrate, endocytose/process antigen, or express MHC II.
• Have: Fc receptors and complement receptors (CD21, CD35).
• Function:
• Retain antigen-antibody complexes on surface.
• Present unprocessed antigen to B cells in germinal centers.
• Support B cell selection and maturation (plasma cells & memory B cells).
• Interact with CD4+ helper T cells and B cells for high-affinity antibody production.